Home › Head and Neck Squamous Cell Carcinoma › Texas › Tyler
Head and Neck Squamous Cell Carcinoma clinical trials in Tyler, TX
6 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Tyler (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #70, Tyler
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
RecruitingPhase 3
- UT Health East Texas HOPE Cancer Center, Tyler
A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC
RecruitingPhase 2
- Site US074, Tyler
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- The University of Texas Health Science Center at Tyler, Tyler
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- Texas Oncology, Tyler
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- UT Health East Texas HOPE Cancer Center, Tyler
- UT Health East Texas Hope Cancer Center, Tyler
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- New York City, NY39 studies
- Nashville, TN39 studies
- St. Louis, MO28 studies
- Arlington, VA26 studies
- Chicago, IL26 studies
- Philadelphia, PA26 studies
- Atlanta, GA24 studies
- San Antonio, TX22 studies
- Pittsburgh, PA22 studies
Other studies in Tyler
- Non-Small Cell Lung Cancer20 studies
- Crohn's Disease17 studies
- Ulcerative Colitis15 studies
- Colorectal Cancer8 studies
- Heart Failure8 studies
- Ovarian Cancer7 studies
- Cancer (all types)7 studies
- Endometrial Cancer6 studies
- Breast Cancer6 studies
- Small Cell Lung Cancer5 studies
- Inflammatory Bowel Disease5 studies
- Digestive Diseases5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.